Chronic conditions are the leading cause of death in the United States and account for the majority of healthcare spending – more than 75 cents of every dollar we spend. The widespread problems and rising rates of chronic health issues pose a significant and unsustainable burden on the U.S. healthcare system.
We cannot effectively address escalating healthcare costs without addressing the problem of chronic disease and its solution: prevention.
Local hospital promoting healthy hearts
Montgomery Hospital in Norristown advocating for awareness during National Heart Month.
National Wear Red Day
University hospital seeks to increase awareness about heart disease in women.
Rise in whooping cough cases results in a public health alert
Number of reported cases in Montgomery County has more than quadrupled since last year.
National campaign to prevent Healthcare-Associated Infections
The Not on My Watch campaign facilitates awareness and educates health practitioners on prevention strategies to curb this international health crisis. Learn more about the impact and how you can help…
Flu Cases Increase in Erie County
Rise in the number of cases of Erie County children coming down with the flu.
Local hospitals reducing the incidence of SIDS
In combination with other programs and initiatives, Chester County Hospital and Paoli Hospital have started wrapping newborns in SleepSacks – a specially-designed blanket.
Fight against fat goes high-tech with new devices
Philadelphia Inq reports:
ALHAMBRA, Calif. – The fight against fat is going high-tech. To get an inside look at eating and exercise habits, scientists are developing wearable wireless sensors to monitor overweight and obese people as they go about their daily lives.
The experimental devices are designed to keep track of how many minutes they work out, [...]
FDA clears Cepheid molecular test for vanA gene
Philadelphia Inq reports:
SUNNYVALE, Calif. – Cepheid said Wednesday it received regulatory clearance to sell a test that detects a gene associated with resistance to a powerful antibiotic.
The molecular diagnostics company said the Food and Drug Administration approved its Xpert vanA test, which is designed to detect a gene connected with resistance to the antibiotic vancomycin, [...]
Cytokinetics ends cancer deal with GlaxoSmithKline
Philadelphia Inq reports:
NEW YORK – Cytokinetics Inc. said Wednesday it ended a deal with GlaxoSmithKline PLC that had focused on developing a potential cancer treatment, sending shares sharply lower in after-hours trading.
Cytokinetics said, effective Feb. 28, all rights for the potential cancer treatment GSK-923295 will revert back to the biotechnology company. GlaxoSmithKline will still be [...]